• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危型人乳头瘤病毒E6蛋白在p53内有两个不同的结合位点,其中只有一个决定降解作用。

High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.

作者信息

Li X, Coffino P

机构信息

Department of Microbiology and Immunology, University of California, San Francisco, California 94143, USA.

出版信息

J Virol. 1996 Jul;70(7):4509-16. doi: 10.1128/JVI.70.7.4509-4516.1996.

DOI:10.1128/JVI.70.7.4509-4516.1996
PMID:8676476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC190386/
Abstract

Human papillomavirus (HPV) E6 protein can inactivate tumor suppressor p53 by inducing its degradation. We now find that high-risk HPV E6 binds to p53 at two distinct sites; one is within the core structure of p53, and another is at the C terminus of p53. Binding to the core of p53 is required for E6-mediated degradation, as shown by deletion analysis and the properties of a point mutant at residue 135. Both low- and high-risk HPV E6 can bind to a C-terminal region of p53, but these interactions do not induce degradation. These results resolve previous seemingly contradictory findings that attributed the distinctive functional properties of high- and low-risk E6 proteins to either a difference in their abilities to associate with p53 or a difference in their N-terminal structures.

摘要

人乳头瘤病毒(HPV)E6蛋白可通过诱导肿瘤抑制因子p53降解来使其失活。我们现在发现,高危型HPV E6在两个不同位点与p53结合;一个位于p53的核心结构内,另一个位于p53的C末端。缺失分析以及135位残基点突变体的特性表明,与p53核心结合是E6介导降解所必需的。低危型和高危型HPV E6均可与p53的C末端区域结合,但这些相互作用不会诱导降解。这些结果解决了先前看似相互矛盾的发现,即高危型和低危型E6蛋白的独特功能特性要么归因于它们与p53结合能力的差异,要么归因于它们N末端结构的差异。

相似文献

1
High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.高危型人乳头瘤病毒E6蛋白在p53内有两个不同的结合位点,其中只有一个决定降解作用。
J Virol. 1996 Jul;70(7):4509-16. doi: 10.1128/JVI.70.7.4509-4516.1996.
2
Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.p53的降解可被HPV E6序列靶向,这些序列不同于p53结合和反式激活所需的序列。
Cell. 1991 Nov 1;67(3):547-56. doi: 10.1016/0092-8674(91)90529-8.
3
Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.通过抑制蛋白酶体依赖性降解,“高危”而非“低危”人乳头瘤病毒(HPV)E6蛋白的细胞稳态水平会升高,且这一过程与其p53和E6相关蛋白(E6AP)结合能力无关。
Virology. 2002 Jul 20;299(1):72-87. doi: 10.1006/viro.2002.1502.
4
Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins.人乳头瘤病毒16型E6癌蛋白与野生型和突变型人p53蛋白的相互作用。
J Virol. 1992 Aug;66(8):5100-5. doi: 10.1128/JVI.66.8.5100-5105.1992.
5
Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.人乳头瘤病毒E6蛋白导致p53肿瘤抑制蛋白的同源物p73功能失活。
Int J Cancer. 2001 Mar 15;91(6):822-7. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1130>3.0.co;2-0.
6
Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.18型人乳头瘤病毒(HPV - 18)E6在体外和体内介导的p53降解比较显示,基于p53结构和细胞类型存在显著差异,但就HPV - 18 E6突变体而言差异不大。
J Gen Virol. 1998 Aug;79 ( Pt 8):1963-70. doi: 10.1099/0022-1317-79-8-1963.
7
Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins.人乳头瘤病毒E7-E6融合蛋白对视网膜母细胞瘤蛋白的靶向降解
EMBO J. 1992 Jul;11(7):2425-31. doi: 10.1002/j.1460-2075.1992.tb05307.x.
8
Inhibition of p53 DNA binding by human papillomavirus E6 proteins.人乳头瘤病毒E6蛋白对p53 DNA结合的抑制作用。
J Virol. 1994 Jul;68(7):4262-73. doi: 10.1128/JVI.68.7.4262-4273.1994.
9
Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase.人源涂鸦蛋白(Vartul)被高危型乳头瘤病毒E6蛋白和E6相关蛋白泛素连接酶靶向,进行泛素介导的降解。
Mol Cell Biol. 2000 Nov;20(21):8244-53. doi: 10.1128/MCB.20.21.8244-8253.2000.
10
Molecular analysis of the interaction between HPV type 16 E6 and human E6-associated protein.人乳头瘤病毒16型E6与人E6相关蛋白相互作用的分子分析
FEBS Lett. 1997 Oct 13;416(1):6-10. doi: 10.1016/s0014-5793(97)01160-5.

引用本文的文献

1
Lymphatic dissemination of HPV-positive oropharyngeal squamous cell carcinoma: underlying mechanisms and treatment innovations.人乳头瘤病毒阳性口咽鳞状细胞癌的淋巴道播散:潜在机制与治疗创新
Front Immunol. 2025 Jun 2;16:1601572. doi: 10.3389/fimmu.2025.1601572. eCollection 2025.
2
Genome composition-based deep learning predicts oncogenic potential of HPVs.基于基因组组成的深度学习预测 HPV 的致癌潜力。
Front Cell Infect Microbiol. 2024 Jul 22;14:1430424. doi: 10.3389/fcimb.2024.1430424. eCollection 2024.
3
Comparative Analysis of Alpha and Beta HPV E6 Oncoproteins: Insights into Functional Distinctions and Divergent Mechanisms of Pathogenesis.α 和β HPV E6 癌蛋白的比较分析:对功能差异和发病机制不同机制的深入了解。
Viruses. 2023 Nov 14;15(11):2253. doi: 10.3390/v15112253.
4
Suppression of E6 Oncogene Induces Apoptosis in CaSki Cervical Cancer Cells.E6 癌基因的抑制诱导 CaSki 宫颈癌细胞凋亡。
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3389-3395. doi: 10.31557/APJCP.2023.24.10.3389.
5
Advances in Targeted Therapy for the Treatment of Cervical Cancer.宫颈癌靶向治疗的进展
J Clin Med. 2023 Sep 15;12(18):5992. doi: 10.3390/jcm12185992.
6
Feline papillomavirus-associated Merkel cell carcinoma: a comparative review with human Merkel cell carcinoma.猫科动物乳头状瘤病毒相关性 Merkel 细胞癌:与人类 Merkel 细胞癌的比较综述。
J Vet Med Sci. 2023 Nov 18;85(11):1195-1209. doi: 10.1292/jvms.23-0322. Epub 2023 Sep 22.
7
High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation.高危型人乳头瘤病毒致癌 E6/E7mRNA 剪接调控。
Front Cell Infect Microbiol. 2022 Jun 27;12:929666. doi: 10.3389/fcimb.2022.929666. eCollection 2022.
8
Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer.《并肩作战:激素刺激与代谢信号变化如何相互协作,导致 HPV 感染引发宫颈癌》
Int J Mol Sci. 2022 May 2;23(9):5050. doi: 10.3390/ijms23095050.
9
Activating transcription factor 3 mediates apoptotic functions through a p53-independent pathway in human papillomavirus 18 infected HeLa cells.激活转录因子 3 通过一条 p53 非依赖性途径在人乳头瘤病毒 18 感染的 HeLa 细胞中介导凋亡功能。
Virus Genes. 2022 Apr;58(2):88-97. doi: 10.1007/s11262-022-01887-8. Epub 2022 Feb 7.
10
A transcriptomic analysis of malignant transformation of human embryonic esophageal epithelial cells by HPV18 E6E7.人胚胎食管上皮细胞经HPV18 E6E7恶性转化的转录组学分析
Transl Cancer Res. 2020 Mar;9(3):1818-1832. doi: 10.21037/tcr.2020.02.23.

本文引用的文献

1
Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.利用双杂交系统鉴定参与寡聚化的p53结构域。
Oncogene. 1993 Jun;8(6):1693-6.
2
Degradation of ornithine decarboxylase: exposure of the C-terminal target by a polyamine-inducible inhibitory protein.鸟氨酸脱羧酶的降解:一种多胺诱导抑制蛋白对C末端靶标的暴露
Mol Cell Biol. 1993 Apr;13(4):2377-83. doi: 10.1128/mcb.13.4.2377-2383.1993.
3
Analysis of a protein-binding domain of p53.p53蛋白结合结构域的分析
Mol Cell Biol. 1993 Jun;13(6):3811-20. doi: 10.1128/mcb.13.6.3811-3820.1993.
4
Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.E6相关蛋白(E6-AP)的cDNA克隆与表达,E6-AP是一种介导人乳头瘤病毒E6癌蛋白与p53相互作用的蛋白质。
Mol Cell Biol. 1993 Feb;13(2):775-84. doi: 10.1128/mcb.13.2.775-784.1993.
5
p53 domains: identification and characterization of two autonomous DNA-binding regions.p53结构域:两个自主DNA结合区域的鉴定与表征
Genes Dev. 1993 Dec;7(12B):2575-86. doi: 10.1101/gad.7.12b.2575.
6
A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.当从野生型p53蛋白而非致癌性突变型p53蛋白产生时,来自p53中央区域的蛋白水解片段具有显著的序列特异性DNA结合活性。
Genes Dev. 1993 Dec;7(12B):2565-74. doi: 10.1101/gad.7.12b.2565.
7
The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.p53的DNA结合结构域包含四个保守区域和主要的突变热点。
Genes Dev. 1993 Dec;7(12B):2556-64. doi: 10.1101/gad.7.12b.2556.
8
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.相关的20K调节亚基在体内对细胞周期蛋白依赖性激酶2(CDK2)活性的抑制作用。
Nature. 1993 Dec 16;366(6456):707-10. doi: 10.1038/366707a0.
9
p21 is a universal inhibitor of cyclin kinases.p21是细胞周期蛋白激酶的通用抑制剂。
Nature. 1993 Dec 16;366(6456):701-4. doi: 10.1038/366701a0.
10
WAF1, a potential mediator of p53 tumor suppression.WAF1,一种p53肿瘤抑制的潜在介导因子。
Cell. 1993 Nov 19;75(4):817-25. doi: 10.1016/0092-8674(93)90500-p.